These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33 related articles for article (PubMed ID: 22795892)
1. Group 1B phospholipase A₂ inactivation suppresses atherosclerosis and metabolic diseases in LDL receptor-deficient mice. Hollie NI; Konaniah ES; Goodin C; Hui DY Atherosclerosis; 2014 Jun; 234(2):377-80. PubMed ID: 24747111 [TBL] [Abstract][Full Text] [Related]
2. Genetic deletion of MMP12 ameliorates cardiometabolic disease by improving insulin sensitivity, systemic inflammation, and atherosclerotic features in mice. Amor M; Bianco V; Buerger M; Lechleitner M; Vujić N; Dobrijević A; Akhmetshina A; Pirchheim A; Schwarz B; Pessentheiner AR; Baumgartner F; Rampitsch K; Schauer S; Klobučar I; Degoricija V; Pregartner G; Kummer D; Svecla M; Sommer G; Kolb D; Holzapfel GA; Hoefler G; Frank S; Norata GD; Kratky D Cardiovasc Diabetol; 2023 Nov; 22(1):327. PubMed ID: 38017481 [TBL] [Abstract][Full Text] [Related]
3. Multifaceted roles of Meg3 in cellular senescence and atherosclerosis. Cheng X; Shihabudeen Haider Ali MS; Baki VB; Moran M; Su H; Sun X Atherosclerosis; 2024 May; 392():117506. PubMed ID: 38518516 [TBL] [Abstract][Full Text] [Related]
4. Changes in spontaneous thrombolytic activity during progression of atherosclerosis in Apo Sato T; Yoshimura M; Sanda T; Hyodo K; Yamamoto J; Ishii H; Yamashita T Int J Clin Exp Pathol; 2018; 11(9):4521-4528. PubMed ID: 31949849 [TBL] [Abstract][Full Text] [Related]
6. Structure-based identification of novel PPAR gamma ligands. da Silva FM; dos Santos JC; Campos JL; Mafud AC; Polikarpov I; Figueira AC; Nascimento AS Bioorg Med Chem Lett; 2013 Nov; 23(21):5795-802. PubMed ID: 24075729 [TBL] [Abstract][Full Text] [Related]
7. PPARγ partial agonist LPSF/GQ-16 prevents dermal and pulmonary fibrosis in HOCl-induced systemic sclerosis (SSc) and modulates cytokine production in PBMC of SSc patients. de Almeida AR; Dantas AT; de Oliveira Gonçalves ME; Chêne C; Jeljeli M; Chouzenoux S; Thomas M; Cunha EGC; de Azevedo Valadares LD; de Melo Gomes JV; de Paula SKS; da Rocha Pitta MG; da Rocha Pitta I; de Melo Rêgo MJB; Pereira MC; Duarte ALBP; Abdalla DSP; Nicco C; Batteux F; da Rocha Pitta MG Inflammopharmacology; 2024 Feb; 32(1):433-446. PubMed ID: 37477795 [TBL] [Abstract][Full Text] [Related]
8. Changes to Urinary Proteome in High-Fat-Diet Hua Y; Meng W; Wei J; Liu Y; Gao Y Biomolecules; 2022 Oct; 12(11):. PubMed ID: 36358920 [TBL] [Abstract][Full Text] [Related]
9. Crystal structure and conformational analysis of 2-hy-droxy-3-(2-methyl-prop-1-en-1-yl)naphthalene-1,4-dione. Alcantara Emiliano S; Welma Duarte Silva S; Alves Pereira M; R Dos Santos Malta V; Luciano Balliano T Acta Crystallogr E Crystallogr Commun; 2016 Feb; 72(Pt 2):188-90. PubMed ID: 26958384 [TBL] [Abstract][Full Text] [Related]
10. A facile synthesis and antimicrobial activity evaluation of sydnonyl-substituted thiazolidine derivatives. Shih MH; Xu YY; Yang YS; Lin GL Molecules; 2015 Apr; 20(4):6520-32. PubMed ID: 25871371 [TBL] [Abstract][Full Text] [Related]
11. LPSF/GQ-02 inhibits the development of hepatic steatosis and inflammation in a mouse model of non-alcoholic fatty liver disease (NAFLD). Soares e Silva AK; de Oliveira Cipriano Torres D; dos Santos Gomes FO; dos Santos Silva B; Lima Ribeiro E; Costa Oliveira A; dos Santos LA; de Lima Mdo C; Pitta Ida R; Peixoto CA PLoS One; 2015; 10(4):e0123787. PubMed ID: 25875942 [TBL] [Abstract][Full Text] [Related]
12. Akt2/LDLr double knockout mice display impaired glucose tolerance and develop more complex atherosclerotic plaques than LDLr knockout mice. Rensing KL; de Jager SC; Stroes ES; Vos M; Twickler MT; Dallinga-Thie GM; de Vries CJ; Kuiper J; Bot I; von der Thüsen JH Cardiovasc Res; 2014 Feb; 101(2):277-87. PubMed ID: 24220638 [TBL] [Abstract][Full Text] [Related]
13. Endothelium-Derived Nitric Oxide as an Antiatherogenic Mechanism: Implications for Therapy. Sukhovershin RA; Yepuri G; Ghebremariam YT Methodist Debakey Cardiovasc J; 2015; 11(3):166-71. PubMed ID: 26634024 [TBL] [Abstract][Full Text] [Related]
14. [Anti-atherosclerotic effect of pioglitazone--the first evidence of the role of triglyceride/HDL ratio]. Császár A Lege Artis Med; 2011 Feb; 21(2):105-11. PubMed ID: 21710708 [TBL] [Abstract][Full Text] [Related]
15. Effect of new thiazolidine derivatives LPSF/GQ-02 and LPSF/GQ-16 on atherosclerotic lesions in LDL receptor-deficient mice (LDLR(-/-)). Soares E Silva AK; de Oliveira Cipriano Torres D; Santos Rocha SW; dos Santos Gomes FO; dos Santos Silva B; Donato MA; Raposo C; Santos AC; de Lima Mdo C; Galdino SL; da Rocha Pitta I; de Souza JR; Peixoto CA Cardiovasc Pathol; 2013; 22(1):81-90. PubMed ID: 22795892 [TBL] [Abstract][Full Text] [Related]
16. Chronic LPSF/GQ-02 treatment attenuates inflammation and atherosclerosis development in LDLr Silva AKSE; Gomes FODS; Santos Silva BD; Ribeiro EL; Oliveira AC; Araújo SMDR; de Lima IT; Oliveira AGV; Rudnicki M; Abdalla DSP; Lima MDCA; Pitta IDR; Peixoto CA Eur J Pharmacol; 2016 Nov; 791():622-631. PubMed ID: 27693798 [TBL] [Abstract][Full Text] [Related]